University Of Notre Dame Du Lac Amarin Corp Plcuk Transaction History

University Of Notre Dame Du Lac

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $297,884 - $514,754	-62,319 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$4.0 - $21.53 $71,388 - $384,245	17,847 Added 40.13%	62,319 $249,000
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $239,475 - $414,357	-17,179 Reduced 27.86%	44,472 $953,000
Q3 2019 Nov 13, 2019	SELL	$13.89 - $23.16 $2.1 Million - $3.5 Million	-151,299 Reduced 71.05%	61,651 $935,000
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $1.04 Million - $1.31 Million	64,113 Added 43.08%	212,950 $4.13 Million
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $202,176 - $358,016	16,033 Added 12.07%	148,837 $3.09 Million
Q4 2018 Feb 13, 2019	BUY	$12.41 - $22.98 $1.65 Million - $3.05 Million	132,804 New	132,804 $1.81 Million
Q4 2017 Feb 13, 2018	SELL	$3.06 - $4.09 $2.46 Million - $3.29 Million	-803,888 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$3.03 - $3.72 $2.44 Million - $2.99 Million	803,888	803,888 $2.81 Million

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

Stay updated on University Of Notre Dame Du Lac with notifications on news.